BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27

• Press Releases

  ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET

  July 24, 2026

   · 

  1 min read
• Press Releases

  MannKind Announces FDA Approval of Furoscix ReadyFlow™, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the Treatment of Edema in Adults with Heart Failure or Chronic Kidney Disease

  July 24, 2026

   · 

  9 min read
• Press Releases

  Merck Announces Initial Access Plans for Alimatravir, an Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis in Phase 3 Development

  July 24, 2026

   · 

  11 min read
• Press Releases

  Sensient Technologies Corporation Reports Results for the Quarter Ended June 30, 2026

  July 24, 2026

   · 

  17 min read
• 

  Psychedelics

  Lilly’s $3.8B psychedelics bet won’t open the M&A floodgates

  Eli Lilly’s $3.8 billion play for AtaiBeckley has fueled speculation that Big Pharma is ready to embrace psychedelics. But while the acquisition does validate the drug class, analysts say it is unlikely to trigger a broad wave of Big Pharma deals.

  July 24, 2026

   · 

  3 min read

   · 

  Gabrielle Masson
• Press Releases

  Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up To Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan

  July 24, 2026

   · 

  6 min read
• Press Releases

  Persica Pharmaceuticals presents new analyses of microbiology assay sensitivity and intradiscal antibiotic exposure response in chronic Low Back Pain at ASPN 2026 Annual Conference

  July 24, 2026

   · 

  5 min read
• Press Releases

  GSK’s Shingrix (Recombinant Zoster Vaccine) prefilled syringe presentation approved in Canada

  July 24, 2026

   · 

  7 min read
• Press Releases

  Enhertu® Plus Pertuzumab Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with HER2 Positive Metastatic Breast Cancer

  July 24, 2026

   · 

  13 min read
• Press Releases

  NanoViricides Announces Pricing of ~$3.8 Million Registered Direct Offering

  July 24, 2026

   · 

  4 min read